Press Release: BD Appoints Ferass Abuzaina as Worldwide President of Surgery

Dow Jones
10/06

FRANKLIN LAKES, N.J., Oct. 6, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company) $(BDX)$, a leading global medical technology company, today announced that Ferass Abuzaina has been named worldwide president of the Surgery business unit at BD, effective immediately.

Abuzaina will be responsible for driving the global strategic, operational, and commercial performance of Surgery. He will be based out of BD Surgery's headquarters in Warwick, RI, and will report to Peter Menziuso, executive vice president and president of the Interventional segment.

"Surgery is well-positioned for its next chapter of growth, and Ferass is the right leader to help us build on that momentum," said Menziuso. "He combines a deep understanding of our business with a strong commitment to innovation, execution and serving customers. I am confident his leadership will help us continue advancing solutions that improve outcomes for patients and clinicians around the world."

Abuzaina currently serves as Worldwide VP/GM, Advanced Repair and Reconstruction, within Surgery. He joined BD in 2013 and has held leadership positions across multiple BD businesses, with experience spanning research and development, strategy and business development. Abuzaina has played an important role in advancing Surgery's innovation pipeline, commercial excellence and operational performance.

He earned a Bachelor of Science, Master of Science and Ph.D. in Chemical Engineering from New York University's Tandon School of Engineering, as well as a Master of Business Administration from the University of Connecticut School of Business.

About BD

BD is one of the world's largest pure-play medical technology companies with a Purpose of advancing the world of health(TM) by driving innovation across medical essentials, connected care, biopharma systems and interventional. The company supports those on the frontlines of healthcare by developing transformative technologies, services and solutions that optimize clinical operations and improve care for patients. Operating across the globe, with more than 60,000 employees, BD delivers billions of products annually that have a positive impact on global healthcare. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase clinical efficiency, improve safety and expand access to healthcare. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/, X or Instagram @becton_dickinson.

 
Contacts: 
Media                  Investors 
---------------------  -------------------------- 
Matt Marcus            Shawn Bevec 
 VP, Public Relations   SVP, Investor Relations 
 Matt.Marcus@bd.com     Investor_Relations@bd.com 
 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-appoints-ferass-abuzaina-as-worldwide-president-of-surgery-302899137.html

SOURCE BD

 

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10